Comparison

MK-677 vs Sermorelin

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

MK-677

Also: Ibutamoren, Nutrobal

Clinical Trials

An orally active growth hormone secretagogue that mimics ghrelin. Not a peptide technically, but frequently discussed alongside GH peptides due to similar effects.

Growth HormoneHuman Trials
Sermorelin

Also: Geref, GRF 1-29

Preclinical

A truncated analog of natural GHRH containing the first 29 amino acids. Previously FDA-approved for pediatric GH deficiency, now used off-label for adult hormone optimization.

Growth HormoneAnimal Studies

Key Comparison Insights

  • Both peptides belong to the Growth Hormone category, suggesting similar primary applications.
  • MK-677 has stronger research evidence (Human Trials) compared to Sermorelin (Animal Studies).

Detailed Comparison

AttributeMK-677Sermorelin
CategoryGrowth HormoneGrowth Hormone
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionMK-677 binds to ghrelin receptors (GHSR) in the brain, stimulating sustained GH release and increasing IGF-1 levels. Unlike injectable GHRPs, it's orally bioavailable and has a long half-life providing 24-hour GH elevation.Sermorelin is bioidentical to the active portion of endogenous GHRH. It stimulates the pituitary's natural production and release of growth hormone, maintaining normal feedback mechanisms and pulsatile GH release patterns.
Common Dosing
10-25 mg daily
Once daily, often before bed
200-500 mcg before bed
Once daily, typically before bed
AdministrationOralSubcutaneous injection at bedtime
Typical Duration8-12 weeks or longer3-6 months typical
Best Time to TakeBefore bedBefore bed (fasted)
Possible Side Effects
May vary by individual
  • Increased appetite and hunger
  • Weight gain
  • Water retention
  • Insulin resistance
  • Elevated blood glucose
  • +3 more
  • Facial flushing (most common)
  • Injection site reactions
  • Headache
  • Nausea
  • Dizziness
  • +4 more
Research SummaryStudies show significant increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. Research in elderly shows reversal of diet-induced nitrogen wasting. Long-term studies demonstrate sustained efficacy.Extensive clinical research from FDA approval process. Studies demonstrate restoration of youthful GH levels, improved sleep quality, increased lean body mass, and enhanced recovery. Generally preserves natural GH axis better than exogenous GH.

Frequently Asked Questions: MK-677 vs Sermorelin

What is the difference between MK-677 and Sermorelin?

MK-677 is a growth hormone peptide that an orally active growth hormone secretagogue that mimics ghrelin. not a peptide technically, but frequently discussed alongside gh peptides due to similar effects. Sermorelin is a growth hormone peptide that a truncated analog of natural ghrh containing the first 29 amino acids. previously fda-approved for pediatric gh deficiency, now used off-label for adult hormone optimization. The main differences lie in their mechanisms of action and clinical applications.

Which is better, MK-677 or Sermorelin?

Neither is universally "better" - the choice depends on your specific goals. MK-677 is typically used for growth hormone purposes, while Sermorelin is used for growth hormone. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can MK-677 and Sermorelin be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using MK-677 and Sermorelin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of MK-677 and Sermorelin is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.